- Home
- WIA vs NVCT Comparison
WIA vs NVCT Comparison
Compare WIA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WIA | NVCT |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.5M | 220.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | WIA | NVCT |
|---|---|---|
| Price | $8.35 | $8.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 39.2K | ★ 61.6K |
| Earning Date | 01-01-0001 | 02-11-2026 |
| Dividend Yield | ★ 12.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.56 | $5.55 |
| 52 Week High | $8.91 | $11.52 |
Technical Indicators
Market Signals| Indicator | WIA | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 65.54 | 56.34 |
| Support Level | $8.33 | $8.12 |
| Resistance Level | $8.38 | $9.22 |
| Average True Range (ATR) | 0.04 | 0.47 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 100.00 | 63.50 |
Price Performance
Historical ComparisonAbout WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.